Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00437996
Other study ID # 2006.424
Secondary ID
Status Completed
Phase Phase 3
First received February 19, 2007
Last updated June 26, 2009
Start date February 2007
Est. completion date January 2008

Study information

Verified date June 2009
Source Hospices Civils de Lyon
Contact n/a
Is FDA regulated No
Health authority France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study type Interventional

Clinical Trial Summary

Addition of clonidine to an epidural mixture of local anaesthetic and morphine improves analgesia and reduces the frequency of motor blockade during epidural analgesia. several side effects are possible mostly somnolence and hypotension. Association of continuous clonidine infusion with low concentrations of levobupivacaïne and sufentanil was not studied during labour. The objective of this study is to compare the effectiveness and the side effects of a PCEA with levobupivacaïne 0,0625 % and sufentanil 0.25 microg.ml-1, without addition of clonidine, and with addition of clonidine at a concentrations of 2 microg.ml-1.


Recruitment information / eligibility

Status Completed
Enrollment 85
Est. completion date January 2008
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Patients of ASA class I or II

- Variable parity

- Aged of 18 years or more

- With a normal pregnancy

- Cervical dilation between 3 and 8 cm)

- Wishing an epidural analgesia

- Normal childbirth

- Giving their written assent

- Affiliated with a social security system

- Must have had an anaesthesia consultation more than 48 hours before inclusion.

Exclusion Criteria:

- Request of the patient

- Failure of epidural analgesia

- Childbirth in the 90 minutes following the induction of analgesia

- Realization of a Caesarean section

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Drug:
Clonidine

Levobupivacaine

Sufentanil


Locations

Country Name City State
France Anesthesie Reanimation - Gynecologie - Hopital de La Croix Rousse Lyon
France Henri Jacques CLEMENT Lyon

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Score of quality at the time of the childbirth based on a 4-point scale : motor blockade - no sensation - nonpainful sensation - pain.
Secondary Motor blockade quantification by a score of modified Bromage specific way.
Secondary Labor analgesia.
Secondary Circulatory parameters(arterial pressure and heart rate will be noticed at 5 - 10 - 15 - 20 - 30 - 60 minutes and every hour until childbirth).
See also
  Status Clinical Trial Phase
Completed NCT00341263 - Maternal and Umbilical Cord Hormone Concentrations in Twin and Singleton Pregnancies
Completed NCT01907620 - Circulating Oxidative Stress and Gestational Hypertension. Study of the Evolution of Free-radical Markers of Oxidative Stress From Before to After Childbirth in Two Groups of Women: Normal Pregnancy and Pre-eclampsia. N/A
Completed NCT03692923 - VIRTUAL COMMUNITY for PREGNANT WOMEN N/A
Recruiting NCT06133621 - Determination of Reference Values for Diluted Russell's Viper Venom Time (dRVVT) Specific to Pregnant Women (GRAPL)
Recruiting NCT04400084 - Using Cotyledon Perfusion to Study Drugs Transfer Across the Placenta
Completed NCT04215484 - Placenta Accreta New Detection Procedure by Rapid Assessment of Serum BNP